VKTX Company Profile and Key Details

Q: Who are the executives of VKTX?

Mr. Michael MorneauVice President of Fin. & Admin.Dr. Brian Lian Ph.D.Pres, Chief Executive Officer & DirectorMr. Gregory S. ZanteChief Financial OfficerMs. Marianne ManciniChief Operating OfficerDr. Geoffrey E. Barker Ph.D.Senior Vice President of Pharmaceutical Devel.

NASDAQ : VKTX

Viking Therapeutics

$34.08

-1.9-5.28%

Open: 10:38 AM

55.83

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Viking Therapeutics, Inc. (VKTX) stock declined over -5.28%, trading at $34.08 on NASDAQ, down from the previous close of $35.98. The stock opened at $35.65, fluctuating between $34.07 and $35.79 in the recent session.

Stock Snapshot

35.98

Prev. Close

3.98B

Market Cap

34.065

Day Low

-8.23

P/E Ratio

-4.14

EPS (TTM)

-0.73

Cash Flow per Share

35.65

Open

116.65M

Number of Shares

35.79

Day High

97.02%

Free Float in %

3.48

Book Value

394.5K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 19, 2026	34.10	36.26	33.83	35.98	2.68M
Aug 18, 2026	33.42	33.94	33.00	33.37	1.19M
Aug 17, 2026	33.13	33.83	32.76	33.63	1.52M
Aug 14, 2026	32.56	33.28	32.33	33.19	1.18M
Aug 13, 2026	33.86	33.97	32.53	32.94	3.7M
Aug 12, 2026	34.07	34.74	33.50	34.02	1.45M
Aug 11, 2026	34.71	34.85	33.62	33.80	1.01M
Aug 10, 2026	33.93	34.70	33.80	34.44	1.61M
Aug 07, 2026	33.82	34.33	33.21	34.26	1.4M
Aug 06, 2026	33.50	34.20	33.10	33.30	1.28M
Aug 05, 2026	33.19	34.08	32.96	33.51	1.96M
Aug 04, 2026	32.95	33.62	32.58	32.94	1.69M
Aug 03, 2026	31.68	32.73	31.28	32.61	1.59M
Jul 31, 2026	33.40	33.75	31.48	31.74	1.86M
Jul 30, 2026	33.52	33.61	30.80	33.11	3.5M
Jul 29, 2026	33.86	34.01	32.84	33.43	2.89M
Jul 28, 2026	34.67	34.81	32.72	33.86	2.33M
Jul 27, 2026	35.41	36.12	34.64	34.87	1.89M
Jul 24, 2026	35.54	35.77	34.39	34.79	1.84M
Jul 23, 2026	36.65	36.81	35.36	35.39	3.24M

Contact Details

San Diego, CA 92121

United States

https://www.vikingtherapeutics.com 858 704 4660

About Company

Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.

Stock Peers

ARGX

39.87+4.02%

argenx SE$1,032.86 REGN

30.6+3.78%

Regeneron Pharmaceuticals, Inc.$840.84 VRTX

23.87+4.52%

Vertex Pharmaceuticals Incorporated$552.06 MDGL

15.79+3.01%

Madrigal Pharmaceuticals, Inc.$540.16 UTHR

10.87+2.10%

United Therapeutics Corporation$529.14 PRAX

16.35+4.42%

Praxis Precision Medicines, Inc.$386.19 ONC

7.71+2.09%

BeOne Medicines AG$376.86 KRYS

10.52+3.16%

Krystal Biotech, Inc.$343.34 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

3.12+1.08%

Ligand Pharmaceuticals Incorporated$290.71

Frequently Asked Questions

What is the current Viking Therapeutics, Inc. (VKTX) stock price?

Viking Therapeutics, Inc. (NASDAQ: VKTX) stock price is $34.08 in the last trading session. During the trading session, VKTX stock reached the peak price of $35.79 while $34.07 was the lowest point it dropped to. The percentage change in VKTX stock occurred in the recent session was -5.28% while the dollar amount for the price change in VKTX stock was - $1.90.

VKTX's industry and sector of operation?

The NASDAQ listed VKTX is part of Biotechnology industry that operates in the broader Healthcare sector. Viking Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VKTX?

Mr. Michael Morneau
Vice President of Fin. & Admin.
Dr. Brian Lian Ph.D.
Pres, Chief Executive Officer & Director
Mr. Gregory S. Zante
Chief Financial Officer
Ms. Marianne Mancini
Chief Operating Officer
Dr. Geoffrey E. Barker Ph.D.
Senior Vice President of Pharmaceutical Devel.

How VKTX did perform over past 52-week?

VKTX's closing price is 56.71% higher than its 52-week low of $22.96 where as its distance from 52-week high of $43.15 is -16.62%.

How many employees does VKTX have?

Number of VKTX employees currently stands at 65.

Link for VKTX official website?

Official Website of VKTX is: https://www.vikingtherapeutics.com

How do I contact VKTX?

VKTX could be contacted at phone 858 704 4660 and can also be accessed through its website. VKTX operates from 9920 Pacific Heights Boulevard, San Diego, CA 92121, United States.

How many shares of VKTX are traded daily?

VKTX stock volume for the day was 394.5K shares. The average number of VKTX shares traded daily for last 3 months was 2.28M.

What is the market cap of VKTX currently?

The market value of VKTX currently stands at $3.98B with its latest stock price at $34.08 and 116.65M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	65
Beta	0.69
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	65
Beta	0.69
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

VKTX Company Profile and Key Details

Viking Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook